Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Interview: David L. Fischman
4
Mins
April 2024
With over 20 years of experience as a cardiologist, what initially sparked your interest in the field, and continues to motivate you at…
Read more
20th October 2014
Factors Affecting Serum Paraoxonase 1 Activity in Migrant and Resident Gujarati South Asians
Paraoxonase 1 (PON1) protects against the development of atherosclerosis by hydrolysing damaging lipid peroxides formed in low-density lipoprotein (LDL)…
20th October 2014
Rationale for Promising Novel Therapeutic Approach Focused On Endothelin Pathway for Peripheral Arterial Disease
There is evidence to suggest that endothelin (ET-1) is involved in the pathophysiology of peripheral arterial disease (PAD), contributing to…
20th October 2014
Current Controversies in Infective Endocarditis
Infective endocarditis (IE) remains a devastating disease with a high mortality. Its microbiology is changing with increasing incidence of Staphylococcus…
21st February 2014
Novel Anticoagulants in Atrial Fibrillation
This educational seminar, supported by an independent educational grant from Daiichi Sankyo, was held at the AHA congress in Dallas on 19th November 2013.
21st February 2014
Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation – (Engage Af – Timi 48 Trial): Primary Results
The following is an executive summary of the abstract presentation by Prof Robert Giugliano on the ENGAGE AF – TIMI 48 trial primary results.
17th October 2013
New Insights into the Definitive Management of Venous Thromboembolism
This educational symposium, supported by an unrestricted educational grant from Daiichi Sankyo, was given at the European Society of Cardiology (ESC)…
17th October 2013
Ace-Inhibitors and Cardioprotection Open Issues and Future Solutions
The current management of patients with hypertension, especially those with a high risk of coronary artery disease should take into account the role of…
17th October 2013
The Changing Landscape in Oral Anticoagulation - The Last Pieces of the Puzzle
Dabigatran, rivaroxaban, apixaban and edoxaban are four new oral anticoagulants (NOACs). There are an increasing number of indications for which these…
Loading posts...
« Previous
1
…
19
20
21
22
Next »